Expertise in
47
conditions

Dr. Grant C. Lewis

Hematology
Summit Cancer Care At Anderson Care Institute
4700 Waters Ave Ste A, 
Savannah, GA 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Expertise in
47
conditions
Summit Cancer Care At Anderson Care Institute
4700 Waters Ave Ste A, 
Savannah, GA 

Overview

Grant Lewis is a Hematologist practicing medicine in Savannah, Georgia.

Dr. Lewis is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 5 clinical trials. Dr. Lewis is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in SC

Hospital Affiliations

Candler Hospital
Savannah Health Services LLC Dba Memorial Health University Medical Center
East Georgia Regional Medical Center
St Joseph's Hospital - Savannah

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Summit Cancer Care at Anderson Care Institute
4700 Waters Ave Ste A, Savannah, GA 31404

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Procedure, Other
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Daratumumab, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: August 10, 2026
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
View 3 Less Clinical Trials

1 Total Publications

Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 04, 2013
Similar Doctors
Expertise in
91
conditions
Dr. Gary W. Thomas
Hematology | Oncology
Expertise in
91
conditions
Dr. Gary W. Thomas
Hematology | Oncology
Referral may be required

Sc Cancer Specialists-Hilton Head At St. Joseph's/Candler

45 Hospital Center Cmns, 
Hilton Head Island, SC 
 (23.0 miles away)
843-689-2895
Languages Spoken:
English, Castilian, Spanish
See accepted insurances
Accepting New Patients

Gary Thomas is a Hematologist and an Oncologist practicing medicine in Hilton Head Island, South Carolina. Dr. Thomas is highly rated in 91 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Paget Disease of the Breast, Richter Syndrome, and Chronic Lymphocytic Leukemia (CLL). Dr. Thomas is currently accepting new patients.

Expertise in
30
conditions
Dr. Majd Chahin
Hematology
Expertise in
30
conditions
Dr. Majd Chahin
Hematology
Referral may be required

South Carolina Cancer Specialist P.A.

100 Buckwalter Place Blvd Ste 130, 
Bluffton, SC 
 (17.1 miles away)
843-836-7100
Languages Spoken:
English, Arabic, Castilian, Spanish
See accepted insurances
Accepting New Patients

Majd Chahin is a Hematologist practicing medicine in Bluffton, South Carolina. Dr. Chahin is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Sideroblastic Anemia. Dr. Chahin is currently accepting new patients.

Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required

Summit Cancer Care At Anderson Care Institute

4700 Waters Ave Ste A, 
Savannah, GA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Barry Luskey is a Hematologist practicing medicine in Savannah, Georgia. Dr. Luskey is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Myelodysplastic Syndrome (MDS), Multiple Myeloma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Luskey is currently accepting new patients.

Frequently Asked Questions about Dr. Grant C. Lewis

Is Dr. Grant C. Lewis a top-rated expert for Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Grant C. Lewis is classified as an Distinguished expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Grant C. Lewis specialize in?

While Dr. Grant C. Lewis is a Hematology, they have specific expertise in Thrombocytopenia, Schnitzler Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Grant C. Lewis participate in research or clinical trials?

Yes. Dr. Grant C. Lewis has published 1 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Dr. Grant C. Lewis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Grant C. Lewis accept my insurance?

Dr. Grant C. Lewis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lewis's expertise for a condition
ConditionClose
    View All 42 Advanced Conditions
    View All 64 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile